Catherine P. Creuzot-Garcher
Expertise in
21
conditions

Catherine P. Creuzot-Garcher

Dijon, FR 
Expertise in
21
conditions
Dijon, FR 

Overview

Catherine Creuzot-Garcher practices practicing medicine in Dijon, France.

Ms. Creuzot-Garcher is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Endophthalmitis, Vitrectomy, and Cataract Removal.

She is actively involved in clinical research, co-authoring 284 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Dijon, France
Other Locations
Bourgogne, France
Paris, France
Reims, France
Bordeaux, France
Grenoble, France
CHU Nantes
Nantes, France
Université Paris Est Créteil, 40, Avenue De Verdun, Creteil, 94000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Study of Anatomical and Functional Recovery Following Retinal Detachment: Identify Correlations Between Visual Acuity and SD-OCT and Microperimetry Findings.
Study of Anatomical and Functional Recovery Following Retinal Detachment: Identify Correlations Between Visual Acuity and SD-OCT and Microperimetry Findings.
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Procedure
Study Phase: Phase 3
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: Dexamethasone
Study Phase: Phase 2
A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome
A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Device
Study Phase: Not Applicable
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Enrollment Status: Completed
Publish Date: December 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
View 4 Less Clinical Trials

284 Total Publications

Retinal Microvascular Correlates of Cerebral Small Vessel Disease in Older Age.
Retinal Microvascular Correlates of Cerebral Small Vessel Disease in Older Age.
Journal: Neurology
Published: August 12, 2026

Frequently Asked Questions about Catherine P. Creuzot-Garcher

Is Catherine P. Creuzot-Garcher a top-rated expert for Age-Related Macular Degeneration (ARMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Catherine P. Creuzot-Garcher is classified as an Elite expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Catherine P. Creuzot-Garcher participate in research or clinical trials?

Yes. Catherine P. Creuzot-Garcher has published 284 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Catherine P. Creuzot-Garcher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Creuzot-Garcher's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 9 Advanced Conditions
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile